Symptomtext
sore left arm; sore left hip; Sniffles; Trouble sleeping; Tired; Tender and swollen under left arm; Tender and swollen under left arm; Shot # 3- Booster; Shot # 3- Booster; This is a spontaneous report from a contactable consumer (patient) reporting for himself. A 44-year-old male patient received bnt162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Formulation: Solution for injection, Lot Number: 3180), via an unspecified route of administration, administered in Left arm on 16Aug2021 16:30 at the age of 45-years-old as dose 3, single for covid-19 immunisation. Medical history included none. The patient had no known allergies. Concomitant medications included adalimumab (HUMIRA) taken for an unspecified indication, start and stop date were not reported received within 2 weeks of vaccination. The patient previously took first dose of historical vaccine, bnt162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Formulation: Solution for injection) on an unspecified date as single dose and second dose of historical vaccine, bnt162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Formulation: Solution for injection, Lot Number: 6201), via an unspecified route of administration, administered in Left arm on 24Mar2021 08:15 at the age of 44-years-old as single dose for covid-19 immunisation. The patient did not receive any other vaccines within four weeks prior to the COVID vaccine. Facility where the most recent COVID-19 vaccine was administered was Pharmacy or Drug Store. The patient was not diagnosed with COVID-19 prior to vaccination. The patient has not been tested for COVID-19 since the vaccination. Device Date: 17Aug2021. On 16Aug2021 at 16:30, the patient experienced shot # 3- booster (off label use), shot # 3- booster (extra dose administered) and on 16Aug2021 at 21:00, the patient experienced sore left arm, sore left hip, sniffles, trouble sleeping, tired, tender and swollen under left arm. No treatment was received for adverse events. The case was reported as non-serious with no seriousness criteria of resulting in death, Life threatening, Caused/prolonged hospitalization, Disabling/Incapacitating, Congenital anomaly/birth defect. The outcome of events was unknown. Follow-Up (25Aug2021): Follow-up attempts are completed. No further information is expected.